Literature DB >> 1707452

A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.

J M Orrell1, A T Evans, A Grant.   

Abstract

There is considerable variation in the quoted mean numbers of AgNORS per nucleus for benign melanonaevi and malignant melanomas. This is partly attributable to different approaches to AgNOR counting. This study summarizes our experience in devising an optimal technique for counting AgNORs. We show that it is essential to count intra-nucleolar AgNORs in addition to those lying outside the nucleolus to obtain clear separation of naevi from melanoma. Although this seems an onerous task, we further demonstrate that a maximum of only 30 nuclei need to be counted to obtain a mean AgNOR count per nucleus which is representative of the whole lesion. This compares with the arbitrary figure of 100 nuclei chosen by most workers. Only by optimizing and standardizing all aspects of the AgNOR technique including fixation, staining, and counting will mean AgNOR counts per nucleus become a useful quick, reproducible method which can be applied to lesions which pose diagnostic problems such as borderline melanocytic lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707452     DOI: 10.1002/path.1711630309

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.

Authors:  D Ofner; B Bier; S Heinrichs; M Berghorn; M Dünser; H A Hagemann; D Langer; W Böcker; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.

Authors:  Y Kida; Y Takano; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  AgNOR counts in conjunctival malignant melanoma lack prognostic value.

Authors:  A D Paridaens; S Seregard; D Minassian; J L Hungerford; A C McCartney
Journal:  Br J Ophthalmol       Date:  1992-10       Impact factor: 4.638

Review 4.  The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications.

Authors:  C C Yu; A L Woods; D A Levison
Journal:  Histochem J       Date:  1992-03

5.  CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.

Authors:  Rui M Gil da Costa; Eduarda Matos; Alexandra Rema; Célia Lopes; Maria A Pires; Fátima Gärtner
Journal:  BMC Vet Res       Date:  2007-08-21       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.